| Primary |
| Postoperative Care |
28.6% |
| Drug Use For Unknown Indication |
26.4% |
| Cataract Operation |
7.7% |
| Product Used For Unknown Indication |
7.7% |
| Prophylaxis |
4.4% |
| Conjunctivitis |
2.2% |
| Diabetes Mellitus |
2.2% |
| Dry Eye |
2.2% |
| Hypertension |
2.2% |
| Hypotony Of Eye |
2.2% |
| Inflammation |
2.2% |
| Preoperative Care |
2.2% |
| Uveitis |
2.2% |
| Antiinflammatory Therapy |
1.1% |
| Blepharitis |
1.1% |
| Blepharospasm |
1.1% |
| Cardiac Disorder |
1.1% |
| Ciliary Hyperaemia |
1.1% |
| Corneal Epithelium Defect |
1.1% |
| Corneal Infiltrates |
1.1% |
|
| Visual Acuity Reduced |
17.9% |
| Ulcerative Keratitis |
12.8% |
| Keratitis |
7.7% |
| Wound Dehiscence |
7.7% |
| Corneal Disorder |
5.1% |
| Hyperhidrosis |
5.1% |
| Ocular Hyperaemia |
5.1% |
| Stevens-johnson Syndrome |
5.1% |
| Visual Impairment |
5.1% |
| Asthma |
2.6% |
| Blindness |
2.6% |
| Blindness Unilateral |
2.6% |
| Dermatitis Contact |
2.6% |
| Eye Irritation |
2.6% |
| Eye Pain |
2.6% |
| Flat Anterior Chamber Of Eye |
2.6% |
| Gastrointestinal Haemorrhage |
2.6% |
| Medication Error |
2.6% |
| No Adverse Event |
2.6% |
| Pain |
2.6% |
|
| Secondary |
| Postoperative Care |
34.2% |
| Blepharospasm |
5.7% |
| Ciliary Hyperaemia |
5.7% |
| Corneal Epithelium Defect |
5.7% |
| Corneal Infiltrates |
5.7% |
| Corneal Thinning |
5.7% |
| Erythema |
5.7% |
| Lacrimation Increased |
5.7% |
| Pain |
5.7% |
| Preoperative Care |
5.1% |
| Premedication |
3.8% |
| Prophylaxis |
3.2% |
| Drug Use For Unknown Indication |
2.5% |
| Product Used For Unknown Indication |
1.9% |
| Asthma |
0.6% |
| Glaucoma |
0.6% |
| Hypersensitivity |
0.6% |
| Hypertension |
0.6% |
| Ill-defined Disorder |
0.6% |
| Local Anaesthesia |
0.6% |
|
| Ulcerative Keratitis |
42.9% |
| Wound Dehiscence |
10.7% |
| Muscular Weakness |
7.1% |
| Ocular Hyperaemia |
7.1% |
| Visual Acuity Reduced |
7.1% |
| Dermatitis Contact |
3.6% |
| Drug Hypersensitivity |
3.6% |
| Post Procedural Complication |
3.6% |
| Skin Exfoliation |
3.6% |
| Swelling Face |
3.6% |
| Tongue Coated |
3.6% |
| Vision Blurred |
3.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.4% |
| Product Used For Unknown Indication |
11.2% |
| Hypertension |
8.8% |
| Menopausal Symptoms |
7.9% |
| Surgery |
4.8% |
| Uveitis |
3.9% |
| Glaucoma |
3.7% |
| Osteoporosis |
3.7% |
| Asthma |
3.3% |
| Pain |
2.8% |
| Hypothyroidism |
2.6% |
| Depression |
2.4% |
| Diabetes Mellitus |
2.4% |
| Prophylaxis |
2.2% |
| Anticoagulant Therapy |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Hypersensitivity |
1.8% |
| Insomnia |
1.8% |
| Pneumonia |
1.8% |
|
| White Blood Cell Count Increased |
9.6% |
| Postoperative Wound Complication |
8.7% |
| Vomiting |
8.7% |
| Speech Disorder |
6.7% |
| Weight Increased |
6.7% |
| Rectal Haemorrhage |
5.8% |
| Thrombocytopenia |
5.8% |
| Visual Impairment |
5.8% |
| Fatigue |
4.8% |
| Macular Oedema |
3.8% |
| Nausea |
3.8% |
| Pulmonary Embolism |
3.8% |
| Tremor |
3.8% |
| Ventricular Fibrillation |
3.8% |
| Wound Haemorrhage |
3.8% |
| Pain |
2.9% |
| Post Procedural Complication |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Visual Acuity Reduced |
2.9% |
| Wheezing |
2.9% |
|
